02Dec
UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-53811/
Related
On September 24, 2019, the U.S. Department of Labor announced a long-awaited final rule regarding ad...
Read More >
Courts around the country are split on the question of whether Title VII of the Civil Rights Act pro...
Read More >
ERISA requires Summary Plan Descriptions and other disclosures to be "written in a manner calculated...
Read More >
In Retirement Plans Committee of IBM v. Jander, the Supreme Court, in a unanimous opinion, clarified...
Read More >
With the new year quickly approaching, it is important to re-examine the policies and plans that gov...
Read More >
Markets started 2020 witnessing the detrimental impact of the COVID-19 pandemic on the global econom...
Read More >